News and Trends 31 Mar 2023
Destiny Pharma gel reduces nasal staph in surgery patients
Destiny Pharma has revealed data showing its drug reduced Staphylococcus aureus in the nasal passage of pre-op cardiac surgery patients.…
Destiny Pharma plc
- Latest Posts
Sponsored by MC Services
10 Mar 2023Meet some of the biotechs attending Bio-Europe Spring 2023
As Bio-Europe Spring 2023 is set to take place from March 20 to March 22 in Basel, Switzerland, a budding…
More News! 15 Nov 2022
Destiny Pharma’s XF-73 dermal infection project advances to safety study
The second of two planned preclinical safety studies has started for Destiny Pharma’s XF-73 dermal formulation. The company announced the…
News and Trends 19 Jul 2022
Good news for Destiny Pharma’s nasal gel to combat life-threatening infections
Clinical stage biotech company, Destiny Pharma, announced today (July 19) a positive update from the U.S. Food and Drug Administration…
ADVERTISEMENT
News and Trends 7 Jul 2022
Treatments set to improve for lethal lung disease and ulcers following drug synergy data revelation
New data has been published today (July 7) evidencing findings that could lead to better treatment for people with lethal…
